Clinical Application of Tissue Engineered Human Heart Valves Using Autologous Progenitor Cells | Zendy

Serghei Cebotari | Zendy; Artur Lichtenberg | Zendy; I. Tudorache | Zendy; Andres Hilfiker | Zendy; Heike Mertsching | Zendy; Rainer Leyh | Zendy; Thomas Breymann | Zendy; Klaus Kallenbach | Zendy; Maniuc Liviu | Zendy; A Batrinac | Zendy; Repin Oleg | Zendy; Malîga Oxana | Zendy; Anatol Ciubotaru | Zendy; Axel Haverich | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Application of Tissue Engineered Human Heart Valves Using Autologous Progenitor Cells

Author(s) -

Serghei Cebotari,

Artur Lichtenberg,

I. Tudorache,

Andres Hilfiker,

Heike Mertsching,

Rainer Leyh,

Thomas Breymann,

Klaus Kallenbach,

Maniuc Liviu,

A Batrinac,

Repin Oleg,

Malîga Oxana,

Anatol Ciubotaru,

Axel Haverich

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.105.001065

Subject(s) - medicine , heart valve , cd31 , progenitor cell , decellularization , cardiology , heart failure , pulmonary valve , trypsinization , tissue engineering , stem cell , angiogenesis , biomedical engineering , trypsin , microbiology and biotechnology , biochemistry , chemistry , biology , enzyme

Tissue engineering (TE) of heart valves reseeded with autologous cells has been successfully performed in vitro. Here, we report our first clinical implantation of pulmonary heart valves (PV) engineered with autologous endothelial progenitor cells (EPCs) and the results of 3.5 years of follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research